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Abstract 
Erythema  multiforme  major  (EMM)  is  an
acute,  self-limited  mucocutaneous  disease
characterized by the abrupt onset of symmetri-
cal fixed red papules evolving to target lesions.
It is triggered mainly by infections, such as
herpes simplex virus (HSV) and Mycoplasma
pneumoniae, or drugs. In instances of exten-
sive skin lesions with “giant” targets, promi-
nent involvement of several mucous sites and
fever, it may be difficult to distinguish from
Stevens-Johnson syndrome (SJS), a rarer, life-
threatening  reaction  which  is  mainly  drug-
induced. We report a 7-year old boy with SJS
and  Chlamydia  pneumoniae infection  and  3
patients  with  EM  and  co-infection  with
Chlamydia pneumoniae: a 3-year old girl and a
29-year old man developed EMM lesions asso-
ciated  to  Mycoplasma  pneumoniae and
Chlamydia  pneumonia and  a  20-year  old
woman with EMM associated to herpes sim-
plex type 2 and Chlamydia pneumoniae infec-
tion. None of the 4 patients had history of drug
intake in the last two months. 
Chlamydia  pneumoniae is  an  intracellular
bacteria responsible for respiratory infections.
Despite the fact that its role in SJS/EMM has
been rarely reported, our cases suggest that it
may cause SJS and trigger EM when co-infect-
ing a patient, either with Mycoplasma pneumo-
niae or  herpes  simplex.  We  conclude  that
infection by Chlamydia pneumoniae should be
suspected and ruled out in every patient with
SJS/EMM, especially in those with signs of res-
piratory infection.
Introduction
Erythema  multiforme  major  (EMM)  is  an
acute,  self-limiting  mucocutaneous  disease
characterized by the abrupt onset of symmetri-
cal fixed red papules, located primarily on the
extremities, some evolving to target lesions.
1
The incidence of EM has been estimated to
vary  between  0.01%  and  1%.
2 It  is  triggered
mainly by infections, such as herpes simplex
virus (HSV) and Mycoplasma pneumoniae, or
drugs. In instances of extensive skin lesions
with “giant” atypical targets, centripetal disti-
bution,  prominent  involvement  of  several
mucous sites and fever, it may be difficult to
distinguish  from  Stevens-Johnson  syndrome
(SJS), a rarer (1-6 cases per million) and life-
threatening  reaction  which  is  mainly  drug-
induced.
3
Case Reports
We report a 7-year-old boy with a rapidly pro-
gressive macular-papular exanthema evolving
to atypical target lesions involving less than
10% of the body surface, oral mucosa erosions,
conjunctivitis and fever (38ºC) in less than 24
hours (Patient #1 - Figure 1). There was no
history of drug intake in the past two months.
Nicolsky sign was positive. Pulmonary auscul-
tation  was  normal,  but  the  X-ray  revealed  a
bilateral interstitial infiltrate, compatible with
atypical  pneumonia.  Skin  biopsy  specimen
taken from the border of a lesion on the back,
showed  dermo-epidermal  detachment,  apop-
totic keratinocytes and inflammatory cell infil-
trate, compatible with SJS (Figure 2).  
Serum IgG for C. pneumoniae was negative
and IgM was 3.4 U/mL (normal < 0.5U/mL) on
admittance but turned frankly positive (36.7
U/mL) four weeks later. The remaining inves-
tigation showed mild leukocytosis with neu-
trophilia and an elevated reactive C protein.
Blood  and  urine  cultures  were  negative.
Serologies to Herpes simplex, M. pneumoniae,
Parvovirus B19, Varicela zoster virus, Human
Immunodeficiency  Virus  (HIV),  Hepatitis  B
and C, Venereal Disease Research Laboratory
(VDRL),  T.  pallidum Human  Agglutination
(TPHA) and urine Legionella pneumoniaeanti-
gen, were all negative. 
Oral clarithromycin 500 mg twice a day for
ten  days  and  topical  bethametasone  twice  a
day for five days and once a day for a further
five days were prescribed with complete clini-
cal resolution in ten days.
In addition 3 other cases of C. pneumoniae
were demonstrated as co-infection in patients
with EMM. 
Patient #2, a 3-year old girl (Figure 3) devel-
oped  a  confluent  maculopapular  exanthema
evolving to target lesions, localized to the face,
chest and limbs, associated with fever and con-
junctival hyperemia. Serum IgM for both M.
pneumoniae and C. pneumoniae was reactive
by enzyme immunoassay and IgG was negative
suggesting recent infection.
Patient #3, a 29-year old man (Figure 4),
presented  with  a  maculopapular  exanthema
and target lesions, localized to the face, trunk
and limbs, fever and conjunctival hyperemia.
Serology suggested a recent infection for both
M. pneumoniae and C. pneumoniae. 
Patient #4, a 20-year old woman presented
with a generalized targetoid eruption, cheilitis
and fever. Serological tests were positive for
Herpes simplex type 2 IgM, C. pneumoniae IgM
and Herpes simplex type 1 IgG. 
Biopsy was performed on the 3 cases, show-
ing  interface  spongiosis,  individual  necrotic
keratinocytes  and  perivascular  inflammatory
cell infiltrate, supporting the diagnosis of ery-
thema multiforme. Chest radiography was nor-
mal  in  the  3  cases.  Complete  blood  count
revealed  mild  leukocytosis  with  neutrophilia
and an elevated reactive C protein. Polymerase
chain reaction for Herpes simplex in the biopsy
specimen was negative. The remaining inves-
tigation was irrelevant. None of the 3 patients
had history of previous drug intake.  
Patients  #2  and  #3  were  treated  with
azithromycin 500 mg per day for three days
and topical bethametasone twice a day for five
days and once a day for a further five  days.
Patient #4 took clarithromycin 500 mg twice a
day  for  ten  days  and  topical  bethametasone
twice a day for five days and once a day for a
further five days. In the 3 cases, the eruption
subsided  gradually,  with  complete  resolution
in  2-4  weeks.  A  few  months  after  convales-
cence, seroconversion was observed. IgM for
Herpes  simplex  type 2  and  C.  pneumoniae
became negative, but a positive IgG was detect-
ed in the case of patient #4. In patients #2 and
#3, IgM for C. pneumoniae and M. pneumoniae
turned negative and IgG turned positive.
Discussion
C. pneumoniae is a human Gram-negative
pathogen responsible for 5-20% of community-
acquired pneumonias in adults and children.
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It  is  a  significant  cause  of  both  lower  and
upper acute respiratory illness, including atyp-
ical  pneumonia,  bronchitis,  pharyngitis  and
sinusitis, but most cases are mild or asympto-
matic.
5 The  seroprevalence  progressively
increases with age, reaching 50% of antibodies
against  C.  pneumoniae in  the  adult  and
exceeding 80% in the ederly.
6
The ethiopathology of SJS and EMM is poor-
ly  understood,  but  some  mechanisms,  like
immune-mediated vascular injury, cell-mediat-
ed immune response and autoimmune mecha-
nisms are possible.
7,8 EM is often associated
with HSV, type 1 in 50% of cases and less often
type 2.
8,9 The second most reported agent is M.
pneumoniae, occurring in about 5% of cases,
but  other  agents  may  be  implicated.
8 In  the
cases of SJS, drugs are the most important eti-
ologic factors.  
The  most  commonly  used  method  for  the
diagnosis of C. pneumoniae is serology, which
basically offers a retrospective study. In our 4
patients,  a  microimmunofluorescence  test,
which is considered as the “gold standard “ of
acute  infections  because  of  high  sensitivity
and  specificity,  was  performed.
10 For  acute
infection  the  patient  should  show  a  4-fold
increase in the IgG titre, an IgG titre of over
1:512 or a positive IgM titre. On prime infec-
tion, the IgM response usually appears at least
three weeks after the onset of illness and the
IgG response at 6-8 weeks. Because of the rel-
atively long window for serological response in
a primary infection, the antibody response may
be missed if convalescent sera are obtained too
soon. In fact, in some cases of acute infection,
three months were needed for antibodies to be
detected. Although PCR holds promise as a fast
diagnostic tool, there are no standardized PCR
or  other  nucleic  acid  amplification  tests  for
detection of C. pneumoniae.
4
Since no other predisposing factor was pres-
ent, and serology confirmed acute infection,
Patient  #1  had  SJS  due  to  C.  pneumoniae
infection. The other 3 patients had serologies
suggesting that C. pneumoniae was at least a
co-responsible factor for EMM. 
Despite the fact that its role in this skin dis-
ease has been rarely reported, our cases sup-
port the view that a patient co-infection with C.
pneumoniae and either with M. pneumoniae or
Herpes simplex, seems to trigger EMM. It is
possible that the presence of more than one
infectious agent that includes C. pneumoniae
may  predispose  patients  to  a  more  probable
and/or more severe cutaneous reaction.
Besides  SJS/EMM,  C.  pneumoniae is  also
associated with other skin reactions, including
erythema nodosum, and hypersensitivity and
Sweet syndromes.
8
To the best of our knowledge, there has  only
been one report of 2 patients with C. pneumo-
niae and M. pneumoniae co-infection associat-
ed with EMM11, and one report of EMM asso-
ciated  to  C.  pneumoniae alone.
8 No  reports
were found of EM associated to C. pneumoniae
and Herpes simplex type 2 co-infection.
We believe that SJS/EMM associated with C.
pneumoniae is underdiagnosed, because it has
been  rarely  reported  and  physicians  are  not
sufficiently aware to search for it.
1,2,7,9 Patients
presenting with SJS/EMM should be evaluated
for active and latent HSV infection and appro-
priate serological testing for M. pneumoniae.
9
However,  other  infectious  causes  should  be
considered.  A  normal  chest  X-ray  does  not
exclude  M.  pneumoniae or  C.  pneumoniae
infection, because the patient does not neces-
sarily disclose pneumonia despite a relevant
infection, besides the fact that atypical pneu-
monia without evident radiological image can
be present.
9 In the light of this, we think it is
advisable to suspect those agents in patients
with respiratory infection signs and SJS/EMM. 
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